| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 26,54% | 96,95% | 76,05% | 370,91% |
| ISHARES MSCI TAIWAN UCITS ETF USD (DIST) | RVI CHINA | 54,00% | 157,95% | 124,93% | 370,68% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO P H GBP DIS | RVI JAPÓN | 25,88% | 95,70% | 101,42% | 369,82% |
| POLAR CAPITAL JAPAN VALUE R GBP DIS HEDGED | RVI JAPÓN VALOR | 40,24% | 125,40% | 200,93% | 369,46% |
| MAN JAPAN COREALPHA EQUITY D H GBP | RVI JAPÓN | 38,80% | 119,28% | 228,27% | 368,58% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND I USD HEDGED | RVI JAPÓN VALOR | 14,50% | 84,33% | 181,73% | 368,38% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) P-ACC | RVI TECNOLOGÍA | 12,80% | 76,81% | 48,43% | 367,62% |
| BNP PARIBAS US GROWTH I USD CAP | RVI USA CRECIMIENTO | 7,64% | 69,18% | 58,50% | 367,29% |
| JPM TAIWAN A (ACC) EUR | RVI CHINA | 54,86% | 150,13% | 115,70% | 365,28% |
| JPM TAIWAN A (ACC) USD | RVI CHINA | 54,72% | 149,25% | 115,77% | 363,51% |
